List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 56 studies with search of: Open Studies | "Hemophilia A"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Unilateral Knee Replacement
Condition: Hemophilia A
Intervention: Drug: Recombinant Protein-Free Factor VIII (rAHF-PFM)
2 Recruiting Kogenate Liplong Study - BAY 79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A
Condition: Hemophilia A
Interventions: Drug: BAY 79-4980;   Drug: BAY 14-2222
3 Recruiting Study of Ataluren (PTC124™) in Hemophilia A and B
Conditions: Hemophilia A;   Hemophilia B
Intervention: Drug: Ataluren (PTC124)
4 Recruiting Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A
Condition: Severe Hemophilia A
Intervention: Drug: Alphanate SD
5 Recruiting Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens
Condition: Hemophilia A
Intervention: Procedure: No Drug
6 Recruiting Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult Subjects Compared to That of Episodic Treatment. (SPINART)
Condition: Hemophilia A
Intervention: Drug: Recombinant Anti-hemophilic Factor VIII (Kogenate®FS)
7 Recruiting Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor
Conditions: Hemophilia A;   Hemophilia B;   (High-titer) Factor VIII Inhibitor;   (High-titer) Factor IX Inhibitor
Intervention: Biological: Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)
8 Recruiting Individually Tailored Prophylaxis in Patients With Severe Hemophilia A
Condition: Hemophilia A
Intervention: Drug: FVIII
9 Recruiting Study of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (vWF/FVIII), Biostate®, in Subjects With Haemophilia A
Condition: Hemophilia A
Interventions: Biological: Biostate® [SP];   Biological: Biostate® [RP]
10 Recruiting Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A
Condition: Hemophilia A
Intervention: Drug: Kogenate FS, Advate, or Humate-P, Recombinate, Helixate FS
11 Recruiting Rituximab to Treat Severe Hemophilia A
Condition: Hemophilia A
Intervention: Drug: Rituximab
12 Not yet recruiting Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A
Condition: Hemophilia A
Interventions: Biological: recombinant FVIII;   Biological: Kogenate FS
13 Recruiting Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
Conditions: Hemophilia A;   Hemophilia B
Intervention:
14 Recruiting Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia A
Condition: Hemophilia A
Intervention: Biological: Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]
15 Not yet recruiting Study Evaluating Safety and Efficacy of Moroctocog Alfa (AF-CC) in Previously Treated Hemophilia A Patients
Condition: Hemophilia A
Interventions: Drug: Moroctocog alfa ( AF-CC);   Procedure: Laboratory tests
16 Not yet recruiting Interleukin-11 (IL-11) in Moderate or Mild Hemophilia A or Von Willebrand Disease (VWD) Unresponsive to Desmopressin Acetate (DDAVP)
Conditions: Hemophilia A;   Von Willebrand Disease
Intervention: Biological: Neumega (Oprelvekin, Interleukin 11, IL-11)
17 Recruiting Efficacy and Safety of N8 in Haemophilia A Subjects
Condition: Haemophilia A
Interventions: Drug: recombinant factor VIII (N8);   Procedure: Blood drawn for laboratory testing
18 Recruiting Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors
Conditions: Haemophilia A;   Haemophilia B
Intervention: Drug: activated recombinant human factor VII
19 Recruiting Safety and Efficacy of N8 in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543 and NN7008-3545
Condition: Haemophilia A
Intervention: Drug: recombinant factor VIII (N8)
20 Recruiting Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors
Condition: Haemophilia A or B With Inhibitors
Intervention: Drug: activated recombinant human factor VII, long acting

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services